![Lenalidomide-propargyl-C2-amido-Ph-NH2 hydrochloride Catalog No.:M17506-C 5-dihydro-1H-pyrrol-1-yl)methyl]-N-[(2S](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M17506_1634722429.gif?v=1634722431)
Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
5-dihydro-1H-pyrrol-1-yl)methyl]-N-[(2S
and steatosis in alcoholic liver disease mouse model
TG100801 or TG-100801 is a dual inhibitor of both VEGFr2 and the Src family (Src and YES) kinases as a topically administered therapeutic candidate in clinical trials for the treatment of age-related macular degeneration
Smiles: OC(=O)CCCSSC1=CC=CC=N1
Tagalakis AD
Lenalidomide-propargyl-C2-amido-Ph-NH2 hydrochloride Catalog No.:M17506-C 5-dihydro-1H-pyrrol-1-yl)methyl]-N-[(2SLenalidomide propargyl C2 amido Ph NH2 hydrochloride incorporates a cereblon (CRBN) ligand for the E3 ubiquitin ligase and a linker. Lenalidomide propargyl C2 amido Ph NH2 hydrochloride can be used to design the PROTAC MD 224 (HY 114312). Product information Molecular Weight: 480. 94 Formula: C25H25ClN4O4 Chemical Name: 4 amino N [5 [2 (2, 6 dioxopiperidin 3 yl) 1 oxo 3H isoindol 4 yl]pent 4 ynyl]benzamide; hydrochloride Smiles: Cl.
US$ 191.50
US$ 143.00
US$ 101.00
US$ 229.00
US$ 268.50
US$ 257.50
US$ 104.50